Ashapura Options has received Rs 100 crore from Xander Finance for its slum redevelopment project in Mumbai's Ghatkopar area.

The charge sheet named Kiran Thakkar alias Kiran Mala, Girish Patel alias Tommy Patel, Dharmendra Chauhan, Chirag Parikh, Ankush Bansal, hi...

CM Anandi Patel appointed four new chairmen, three new vice-chairmen and 60 members to various boards & corporations of Gujarat government.

"We will invest Rs 25-30 crore in the first phase" said Rajiv Sharma, CEO, Sterling Addlife India, adding that a breakeven was expected in ...

Private equity fund Actis said it will sell its 82 per cent holding in Sterling Hospital, which will be bought by the latter's Chairman Gir...

Devendra Patel has launched Layer’r brand of perfumes and deodorants, following the footprints of his brother, Darshan, who launched Vini C...

Gujarat High Court today expressed satisfaction about the progress made by CBI in the investigation of Ishrat Jahan fake encounter case.

Patel was running Paras till it was bought by Reckitt. He sold the company, known for brands like Moov, Itch Guard and Krack, for 3,200 cor...

Manipal Health Enterprises and Kolkata's AMRI have placed bids in excess of Rs 500 crore to acquire Ahmedabad-based Sterling Hospitals, whi...

Some of the cash-rich India Inc promoters are rolling up sleeves to be active investor managers in the new growth firms.

Barely two days after he sold off Paras Pharmaceuticals, Girish Patel is back to what he does best—building enterprise.

This is a growing opportunity in banking and finance that will help Indian cos — to compete against deep pockets of MNCs — and small — to g...

Darshan Patel, the estranged brother of Paras Pharmaceuticals CMD Girish Patel, is set to take on brands such as DermiCool, ItchGuard and B...

The actor, who had been scouting around for an office for Red Chillies Entertainment, finally zeroed in on a 40,000-square-foot plot. BO We...

Actis has acquired shares from family members, as well as through a Rs 25-crore preferential allotment, industry sources told ET.

Private equity major Actis is close to picking up 10% in the Ahmedabad-based Paras Pharmaceuticals, the company that owns well known brands...

Paras Pharmaceuticals iwants to acquire brands, or OTC companies, that would fit in with its growth plans.